144 related articles for article (PubMed ID: 20667484)
1. Rituximab treatment of systemic lupus erythematosus in controlled trials and in clinical practice: Two sides of the same coin.
Conti F; Perricone C; Ceccarelli F; Valesini G
Autoimmun Rev; 2010 Sep; 9(11):716-20. PubMed ID: 20667484
[No Abstract] [Full Text] [Related]
2. Immunologic reconstitution after rituximab in systemic lupus erythematosus: why should we care?
Anolik J
J Rheumatol; 2011 Apr; 38(4):587-9. PubMed ID: 21459953
[No Abstract] [Full Text] [Related]
3. Three different B-cell depletion (anti-CD20 monoclonal antibodies) treatments for severe resistant systemic lupus erythematosus.
Faria RM; Isenberg DA
Lupus; 2010 Sep; 19(10):1256-7. PubMed ID: 20534646
[No Abstract] [Full Text] [Related]
4. Rituximab - shadow, illusion or light?
van Vollenhoven RF
Autoimmun Rev; 2012 Jun; 11(8):563-7. PubMed ID: 22036829
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic changes of lymphocytes in patients with systemic lupus erythematosus who are in longterm remission after B cell depletion therapy with rituximab.
Iwata S; Saito K; Tokunaga M; Yamaoka K; Nawata M; Yukawa S; Hanami K; Fukuyo S; Miyagawa I; Kubo S; Tanaka Y
J Rheumatol; 2011 Apr; 38(4):633-41. PubMed ID: 21159836
[TBL] [Abstract][Full Text] [Related]
6. Long-term efficacy and safety of rituximab in refractory and relapsing systemic lupus erythematosus.
Catapano F; Chaudhry AN; Jones RB; Smith KG; Jayne DW
Nephrol Dial Transplant; 2010 Nov; 25(11):3586-92. PubMed ID: 20466686
[TBL] [Abstract][Full Text] [Related]
7. Rituximab in the treatment of bullous systemic lupus erythematosus.
Alsanafi S; Kovarik C; Mermelstein AL; Werth VP
J Clin Rheumatol; 2011 Apr; 17(3):142-4. PubMed ID: 21441817
[TBL] [Abstract][Full Text] [Related]
8. B cell or T cell-dominant recurrence after rituximab therapy in patients with SLE.
Iwata S; Saito K; Tokunaga M; Tanaka Y
Ann Rheum Dis; 2012 Oct; 71(10):1749-50. PubMed ID: 22586167
[No Abstract] [Full Text] [Related]
9. Complement C2 deficiency disarranging innate and adaptive humoral immune responses in a pediatric patient: treatment with rituximab.
Hauck F; Lee-kirsch MA; Aust D; Roesler J; Pessler F
Arthritis Care Res (Hoboken); 2011 Mar; 63(3):454-9. PubMed ID: 20890976
[No Abstract] [Full Text] [Related]
10. Serum rituximab levels and efficiency of B cell depletion: differences between patients with rheumatoid arthritis and systemic lupus erythematosus.
Reddy V; Croca S; Gerona D; De La Torre I; Isenberg D; McDonald V; Leandro M; Cambridge G
Rheumatology (Oxford); 2013 May; 52(5):951-2. PubMed ID: 23424262
[No Abstract] [Full Text] [Related]
11. Rituximab: a promising therapy in systemic lupus erythematosus.
Thatayatikom A; White AJ
Autoimmun Rev; 2006 Jan; 5(1):18-24. PubMed ID: 16338207
[TBL] [Abstract][Full Text] [Related]
12. [Molecular targets and their regulation in systemic lupus erythematosus and lupus nephritis].
Takasaki Y
Nihon Jinzo Gakkai Shi; 2012; 54(5):598-602. PubMed ID: 22991839
[No Abstract] [Full Text] [Related]
13. Successful treatment of recurrent pancreatitis secondary to systemic lupus erythematosus with B-cell depletion therapy.
Al-Musawi ZS; Nabar UJ
Arch Iran Med; 2011 Jan; 14(1):66-70. PubMed ID: 21194267
[TBL] [Abstract][Full Text] [Related]
14. B cell elimination in systemic lupus erythematosus.
Furtado J; Isenberg DA
Clin Immunol; 2013 Feb; 146(2):90-103. PubMed ID: 23280492
[TBL] [Abstract][Full Text] [Related]
15. Rituximab as early therapy for pulmonary haemorrhage in systemic lupus erythematosus.
Narshi CB; Haider S; Ford CM; Isenberg DA; Giles IP
Rheumatology (Oxford); 2010 Feb; 49(2):392-4. PubMed ID: 19926673
[No Abstract] [Full Text] [Related]
16. [Rituximab in systemic lupus erythematosus. Part II: review of clinical experience].
Kardynał A; Rudnicka L
Pol Merkur Lekarski; 2010 Aug; 29(170):135-40. PubMed ID: 20842830
[TBL] [Abstract][Full Text] [Related]
17. B-cell-depleting therapy in systemic lupus erythematosus.
Ramos-Casals M; Sanz I; Bosch X; Stone JH; Khamashta MA
Am J Med; 2012 Apr; 125(4):327-36. PubMed ID: 22444096
[TBL] [Abstract][Full Text] [Related]
18. Rituximab and lupus--a promising pair?
Ekö SL; van Vollenhoven RF
Curr Rheumatol Rep; 2014; 16(9):444. PubMed ID: 25074032
[TBL] [Abstract][Full Text] [Related]
19. Rituximab-it was the best of times, it was the worst of times.
Isenberg DA
Autoimmun Rev; 2012 Sep; 11(11):790-1. PubMed ID: 22349619
[TBL] [Abstract][Full Text] [Related]
20. [Rituximab in systemic lupus erythematosus. Part I. Theoretical basis].
Kardynał A; Rudnicka L
Pol Merkur Lekarski; 2010 Aug; 29(170):131-4. PubMed ID: 20842829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
